Latest Articles

Publication Date
FOCL: Robotic focal therapy drives rapid growth, expanding into new indications and global markets - TradingView

FOCL: Robotic focal therapy drives rapid growth, expanding into new indications and global markets TradingView

Published: June 1, 2026, 4:35 p.m.
Bryan Johnson’s Global Praise After Tackling Rare Condition Affecting 1 in 10 - indonesiakini

Bryan Johnson’s Global Praise After Tackling Rare Condition Affecting 1 in 10 indonesiakini

Published: May 29, 2026, 9:27 p.m.
House of Lords Hosts 5th International Conference on Paid Period Leave, Strengthening Global Call for Menstrual Dignity and Workplace Equality - Big News Network.com

House of Lords Hosts 5th International Conference on Paid Period Leave, Strengthening Global Call for Menstrual Dignity and Workplace Equality Big News Network.com

Published: May 29, 2026, 2:04 p.m.
A global conversation on the future of healthcare - .::. UCLA International Institute

A global conversation on the future of healthcare .::. UCLA International Institute

Published: May 27, 2026, 12:18 a.m.
Dostarlimab Plus Chemotherapy Demonstrates Sustained Disease Control in dMMR/MSI-H Advanced Endometrial Cancer - HMP Global Learning Network

Dostarlimab Plus Chemotherapy Demonstrates Sustained Disease Control in dMMR/MSI-H Advanced Endometrial Cancer HMP Global Learning Network

Published: May 26, 2026, 4:46 p.m.
Bryan Johnson praised by women globally after committing to ‘tackle’ condition affecting 1 in 10 - Indy100

Bryan Johnson praised by women globally after committing to ‘tackle’ condition affecting 1 in 10 Indy100

Published: May 26, 2026, 11:32 a.m.
Lesion-centric reprogramming: hydrogel-enabled photothermal reset of endometriosis pain.

Endometriosis-associated pelvic pain represents a prototypical failure of systemic therapy for a locally organized, neuroinflammatory disease. Persistent pain arises from the convergence of estrogen-driven lesion survival, chronic inflammation, fibrosis, and …

Published: May 23, 2026, midnight
ADVANTAGE: Advanced discovery of visceral analgesics by neuroimmune targets and the genetics of extreme human phenotype, a study protocol.

Chronic visceral pain affects over 20% of adults globally but remains poorly understood, significantly impacting quality of life and healthcare costs. Limited understanding and diagnostic misconceptions hinder effective management, particularly …

Published: May 21, 2026, midnight
Merck’s TROP2 ADC opens global women’s cancer push with endometrial win - BioCentury

Merck’s TROP2 ADC opens global women’s cancer push with endometrial win BioCentury

Published: May 18, 2026, 10:04 p.m.
Merck ADC, licensed from China, hits mark in first big global trial - BioPharma Dive

Merck ADC, licensed from China, hits mark in first big global trial BioPharma Dive

Published: May 18, 2026, 4:03 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!